We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing potential new cancer medicines for patients in need of new treatment options. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader. Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing potential new cancer medicines for patients in need of new treatment options. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
Patient Enrollment Resumed in the Investigator-initiated Phase 1/2 Clinical Trial of Seclidemstat in Combination with Azacitidine to Treat Hematologic Cancers Company Implemented Significant...
Company implementing a series of cost-savings measures designed to extend Salariusโ expected cash runway into the first half of 2025 Extended runway supports the generation of additional data...
Expands IP portfolio with composition-of-matter protection into 2039 for novel molecular glues Protein degrader portfolio now includes 17 issued patents across six patent families HOUSTON, Jan...
HOUSTON, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) announces that the hematologic cancer Phase 1/2 clinical trial being conducted at the University of Texas...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0052 | -1.0612244898 | 0.49 | 0.56 | 0.468 | 31228 | 0.5061445 | CS |
4 | -0.1052 | -17.8305084746 | 0.59 | 0.748 | 0.43 | 312123 | 0.52660004 | CS |
12 | -0.0642 | -11.693989071 | 0.549 | 0.7888 | 0.43 | 117729 | 0.53688402 | CS |
26 | -0.2726 | -35.9915500396 | 0.7574 | 0.93 | 0.43 | 74465 | 0.57535745 | CS |
52 | -1.4252 | -74.6178010471 | 1.91 | 2.68 | 0.43 | 82202 | 1.0071901 | CS |
156 | -28.5152 | -98.3282758621 | 29 | 37.75 | 0.43 | 510317 | 17.27567097 | CS |
260 | -288.2652 | -99.8321038961 | 288.75 | 370.385 | 0.43 | 575460 | 28.61075933 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions